Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    833373 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Xolair in Patients With Chronic Sinusitis
Condition: Sinusitis
Intervention: Drug: Anti-IgE antibody omalizumab or placebo
2 Unknown  The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study
Conditions: Nasal Polyp;   Smoking;   Rhinosinusitis;   Allergic Rhinitis;   Deviated Nasal Septum;   ASA Intolerant Asthma
Intervention:

Indicates status has not been verified in more than two years